Cell therapy as a treatment of secondary lymphedema: a systematic review and meta-analysis
Abstract Background Lymphedema, the accumulation of interstitial fluid caused by poor lymphatic drainage, is a progressive and permanent disease with no curative treatment. Several studies have evaluated cell-based therapies in secondary lymphedema, but no meta-analysis has been performed to assess...
Main Authors: | Hector Lafuente, Ibon Jaunarena, Eukene Ansuategui, Arantza Lekuona, Ander Izeta |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-021-02632-y |
Similar Items
-
Biology of Lymphedema
by: Bianca Brix, et al.
Published: (2021-03-01) -
Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema
by: Cynthia J. Sung, et al.
Published: (2022-04-01) -
Lymphatic Connexins and Pannexins in Health and Disease
by: Avigail Ehrlich, et al.
Published: (2021-05-01) -
The Lymphatic Endothelium in the Context of Radioimmuno-Oncology
by: Lucía Suárez, et al.
Published: (2022-12-01) -
Design of an Auxiliary Artificial Lymphatic Vessel in Treatment of Secondary Lymphedema Due to Breast Cancer
by: Gabriela Durán-Aguilar, et al.
Published: (2021-12-01)